Last reviewed · How we verify

NCT03295032

A Mixed-methods Evaluation of an Adapted Acceptance and Commitment Therapy (ACT) Group for Stroke Survivors

Completed NA Last updated 27 September 2017
What this trial tests

NA trial testing Acceptance and Commitment Therapy (ACT) in Stroke in 53 participants. Completed in 29 December 2016.

Timeline
1 March 2016
Primary endpoint
29 December 2016
29 December 2016

Quick facts

Lead sponsorCardiff University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment53
Start date1 March 2016
Primary completion29 December 2016
Estimated completion29 December 2016
Sites4 locations across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Cardiff University

Who can join

18 and older, any sex, with Stroke or Acceptance and Commitment Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stroke is one of the main causes of acquired adult disability in the UK. Many psychological problems can also occur post-stroke; this has a marked impact on health service usage. As such, there is an outstanding need to increase and improve psychological resources within stroke services. The investigators proposed to adapt and evaluate the effectiveness of an acceptance and commitment therapy (ACT) group intervention for adult stroke survivors and their carers. The group will endeavour to promote positive adjustment and reduce levels of depression and anxiety. This study will have two parts.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Acceptance and Commitment Therapy (ACT)

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Cardiff University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03295032.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing